Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is not the pennant I was looking at, but similar. The pennant I am looking at began after we bottomed, and started with a flag pole.
Our low of day last week was the bottom line, on this pennant.
Anyone else fired up, like I am for this week?
http://whythefutureisbrightformannkind.blogspot.com/2016/02/post-sanofi-marketing-strategy-tips-by.html
I hope they publish yours.
One question, Why did Sanofi price Afrezza above MNKD's recommendation, and above an acceptable purchase price for Insurance companies?
What is the intent behind the pricing?
It isn't profits, as pricing is above what the majority of purchasers are willing to pay. They defy the Supply/Demand curve.
Why?
IMO, it was Sanofi's intent to drive MNKD near bankruptcy, and attempt to purchase them cheap.
Is this a pattern for big pharma...
Sure is looking like it. This is giving Matt the Ammo he needs to negotiate a nice parting settlement, I believe.
If a good settlement is not reached, I believe that MNKD sues SNY for a lot more than any proposed settlement would offer.
Matt has leverage either way, imo.
I believe that due to the bullish pennant on the daily chart, we will see a new flag pole created this coming week. I believe that seeing .80's is a thing of the past, if my chart analysis is correct.
The weekly chart is also intriguing, as the MACD looks to crossover this week, along with oversold RSI.
"Seeking Alpha is intentionally misleading investors for their own gain and perhaps others, at the expense of you and all of their readers that rely on what they believe to be honest and open journalism, yet intent of stealing your savings through censorship, and fraudulent reporting."
http://www.stockshortdata.com/2016/02/12/seeking-alpha-exposed-criminal-market-stock-manipulation-part-1/
As you all know, Seeking Alpha has been covering MNKD for some time now.
A very, very long story. You can start by reading the articles here: https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=MNKD
That is the opinion of many.
New Facebook group created: https://www.facebook.com/groups/1650389468546952/?hc_location=ufi
ROFL. Good luck ever picking anything up below .92 after today, ever again, imo.
A SNY settlement, along with Script numbers will ultimately be the factor that drives us, come April when we have Afrezza back home, imo.
Really, where is the evidence that they put a commercial on TV in test markets, as your opinion suggests? Which companies SEC filings are you looking at?
Please let me know, as I would gladly post this info, if it were true.
I have never used a pump and I never will! No shots either! ;) I use #afrezza you inhale it and it drops you instantly! @alanapaigege
— Adam Lasher (@AdamLasher) February 11, 2016
It will be very interesting to see how negotiations go, in regards to a settlement payment to MNKD from SNY, upon the return of Afrezza to MNKD. That will be a great announcement.
I wonder if SNY will overpay, in an attempt to avoid a lawsuit against Sanofi, for sandbagging on Afrezza advertisements?
Their primary in house Diabetes drug was given a commercial asap, but they failed to do the same with Afrezza. At least they spent a few bucks on magazine ads.
Interesting... Green days are ahead, imo! http://www.nasdaq.com/article/notable-wednesday-option-activity-mnkd-tlrd-cbi-cm578184
Speaking of Afrezza safety...
@johnjedwards3 @NBisserbe @deniseroland @simoneill Views are your own, not bought right? https://t.co/BmKsz9hxoj
— Harryx1 (@TheHarryx1) February 10, 2016
@deniseroland Inhaled Insulin (Afrezza) Now Helping Diabetics lose 5+ shots a day & dropping A1cs 1+ pt #RealStory https://t.co/eelB392rgk
— Harryx1 (@TheHarryx1) February 10, 2016
Users are saying that Afrezza works better and faster than everything else. I tend to believe actual users, rather than the words on the paper.
So when do the lawsuits begin against Sanofi? April 5th?
If he makes it, we could see some free advertising! http://www.latimes.com/tn-cpt-et-0213-american-idol-adam-lasher-20150206-story.html
Anyone load the wagon at .88 today?
About time for the SEC to investigate Joshua Schimmer, imo.
That was definitely an issue before Pfeffer took over CEO. Not an issue anymore, imo.
They could simply sell Afrezza to Sanofi, Love this .88 for a nice pick-up to swing trade, imo. Reminds me of when we traded at .66 all day long, then took off the following day.
Well, we have till about June to find out, at the latest, imo. They would probably sell the company if they do not find a partner, imo.
Must find a partner.
.88 bounce?
Options expire today $1